Back to results
US 10,376,490 B2Granted
Pharmaceutical composition containing silybin
AssigneeTasly Pharmaceutical Group Co., Ltd.
InventorsNaifeng Wu, Xijun Yan, He Sun, Kaijing Yan, Yonghong Zhu, Shunnan Zhang, Xiaolin Bai, Yi He, Xiaohui Ma, Ting Li
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition for treating non-alcoholic fatty liver diseases consists of a silybin-phospholipid complex preparation and Pu'er tea/tea product according to a weight ratio of 0.5-2.5:0.3-10, wherein the silybin-phospholipid complex capsule preparation and the Pu'er teat/tea product are separately packaged.
Claims17
A pharmaceutical composition comprising
- biologically active ingredients consisting of a silybin-phospholipid complex pharmaceutical preparation and a Pu'er tea essence or aqueous extract,
- wherein the silybin-phospholipid complex pharmaceutical preparation and the Pu'er tea essence or aqueous extract are each contained in separate packages according to unit dose,
- wherein the separate packages are further contained in a single package,
- wherein the ratio of the silybin-phospholipid complex to the Pu'er tea essence or Pu'er tea extract is 0.5-2.5:0.3-10 (w:w),
- wherein the silybin-phospholipid complex pharmaceutical preparation and the Pu'er tea essence or aqueous extract are administrated in a combination according to respective doses to a subject in need thereof.
2 more elements
Dependencies are inferred from the claim text.